ACHV insider trading
NasdaqCM HealthcareACHIEVE LIFE SCIENCES, INC.: insider trade history from SEC Form 4 filings.
About ACHIEVE LIFE SCIENCES, INC.
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
Company website: www.achievelifesciences.com
ACHV insider activity at a glance
FilingIQ tracks 137 insider transactions for ACHV in filings since Aug 3, 2017. The most recent transaction is dated Aug 19, 2026.
Across the full history, 10 open-market purchases
and 39 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ACHV insider trades is 58.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ACHV Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for ACHV?
- FilingIQ tracks 137 Form 4 insider transactions for ACHV (ACHIEVE LIFE SCIENCES, INC.), covering filings from Aug 3, 2017 onwards. 1 of those are dated within the last 90 days.
- Are ACHV insiders net buyers or net sellers?
- Across the full Form 4 history for ACHV, 10 transactions (7%) were open-market purchases and 39 (28%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ACHV insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is ACHV in?
- ACHIEVE LIFE SCIENCES, INC. (ACHV) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $229.97M.
Methodology & sources
Every ACHV insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.